Trevi Therapeutics, Inc.
TRVI • NASDAQ
Trevi Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer L. Good, with a market cap of $1.7B.
Market Cap$1.7B
Employees25.0
CEOJennifer L. Good
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
TRV
Trevi Therapeutics, Inc. FAQ
Common questions about Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026.
Trevi Therapeutics, Inc. has approximately 25 employees.